Evaluation of safety and efficacy of erlotinib as monotherapy for Chinese patients with advanced non-small cell lung cancer

被引：0
|
作者：
Zhang, Xiao-Tong [1 ]
Li, Long-Yun [1 ]
Wang, Meng-Zhao [1 ]
Zhang, Li [1 ]
Zhong, Wei [1 ]
Wang, Shu-Lan [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    [J]. 中华医学杂志(英文版), 2006, (01) : 63 - 68
  • [2] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Mengzhao LI Longyun WANG Shulan ZHANG Xiaotong ZHONG Wei and ZHANG LiDepartment of Respiratory Diseases Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
    [J]. ChineseMedicalJournal., 2006, (01) - 68
  • [3] Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
    Wang, MZ
    Li, LY
    Wang, SL
    Zhang, XT
    Zhong, W
    Zhang, L
    [J]. CHINESE MEDICAL JOURNAL, 2006, 119 (01) : 63 - 68
  • [4] Efficacy and clinical/molecular predictors of erlotinib monotherapy for Chinese advanced non-small cell lung cancer
    Zhu Yu-jia
    Xia Ying
    Ren Guan-jun
    Wang Meng-zhao
    Zeng Xuan
    Zhang Li
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3200 - 3205
  • [5] Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer A Phase II Study
    Kubota, Kaoru
    Nishiwaki, Yutaka
    Tamura, Tomohide
    Nakagawa, Kazuhiko
    Matsui, Kaoru
    Watanabe, Koshiro
    Hida, Toyoaki
    Kawahara, Masaaki
    Katakami, Nobuyuki
    Takeda, Kohi
    Yokoyama, Akira
    Noda, Kazumasa
    Fukuoka, Masahiro
    Saijo, Nagahiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (12) : 1439 - 1445
  • [6] Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer.
    Zhang, XT
    Li, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 639S - 639S
  • [7] Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status
    Wei Z.
    Mengzhao W.
    Li Z.
    Longyun L.
    Xiaotong Z.
    [J]. BMC Research Notes, 1 (1)
  • [8] ERLOTINIB FOR CHINESE ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Wang, H-P
    Li, Z.
    Wang, M-Z
    Yi, X.
    [J]. RESPIROLOGY, 2011, 16 : 172 - 172
  • [9] Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer
    Karaca, Halit
    Geredeli, Caglayan
    Kaplan, M. Ali
    Demirci, Umut
    Alici, Suleyman
    Artac, Mehmet
    Isikdogan, Abdurrahman
    Benekli, Mustafa
    Balakan, Ozan
    Arpaci, Erkan
    Budakoglu, Burcin
    Uncu, Dogan
    Guler, Tunc
    Berk, Veil
    Ozkan, Metin
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (01): : 1 - 6
  • [10] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Gu, Aiqin
    Shi, Chunlei
    Xiong, Liwen
    Chu, Tianqing
    Pei, Jun
    Han, Baohui
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 90 - 94
12345